Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,638 | 45,379 | 58,849 | 30,793 | 66,824 |
| Receivables | 777 | 882 | 2,761 | 2,068 | N/A |
| TOTAL | $51,527 | $48,685 | $66,078 | $38,674 | $72,928 |
| Non-Current Assets | |||||
| PPE Net | 8,578 | 9,622 | 10,547 | 11,534 | 12,566 |
| Other Non-Current Assets | 83,368 | 85,493 | 87,557 | 89,602 | 93,248 |
| TOTAL | $91,946 | $95,115 | $98,104 | $101,136 | $105,814 |
| Total Assets | $143,473 | $143,800 | $164,182 | $139,810 | $178,742 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,677 | 2,200 | 2,168 | 4,079 | 8,254 |
| Accrued Expenses | 10,832 | 19,262 | 20,106 | 28,469 | 48,233 |
| TOTAL | $22,429 | $30,940 | $31,323 | $41,222 | $64,833 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 77,347 | 79,910 | 82,394 | 84,804 | 89,990 |
| TOTAL | $77,347 | $79,910 | $82,394 | $84,804 | $89,990 |
| Total Liabilities | $99,776 | $110,850 | $113,717 | $126,026 | $154,823 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,047 | 8,755 | 8,732 | 8,718 | 8,537 |
| Common Shares | 9 | 9 | 9 | 9 | 170 |
| Retained earnings | -957,068 | -965,272 | -945,417 | -978,099 | -962,462 |
| TOTAL | $43,697 | $32,950 | $50,465 | $13,784 | $23,919 |
| Total Liabilities And Equity | $143,473 | $143,800 | $164,182 | $139,810 | $178,742 |